[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Biologics and Biosimilars Sales Market Report 2016

October 2016 | 120 pages | ID: G66B710DF38EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Biologics and Biosimilars

Revenue, means the sales value of Biologics and Biosimilars

This report studies sales (consumption) of Biologics and Biosimilars in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
  • Pfizer
  • Roche
  • Amgen
  • AbbVie
  • Sanofi
  • Johnson & Johnson
  • Novo Nordisk
  • Novartis
  • Merck
  • Lilly
  • 3sbio
  • Changchun high tech
  • CP Guojian Pharmacy
  • Biotech Pharma
  • Gelgen Biopharma
  • Sandoz
  • Teva
  • Hospira
  • Mylan
  • 3sbio
  • Changchun high tech
  • CP Guojian Pharmacy
  • Biotech Pharma
  • Gelgen Biopharma
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Biologics and Biosimilars in these regions, from 2011 to 2021 (forecast), like
  • USA
  • China
  • Europe
  • Japan
  • India
  • Southeast Asia
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
  • Classification by Technology
  • Classification by Types
  • Classification by Use
  • Classification by Services
Split by applications, this report focuses on sales, market share and growth rate of Biologics and Biosimilars in each application, can be divided into
  • Tumor
  • Diabetes
  • Cardiovascular
  • Hemophilia
  • Other
Global Biologics and Biosimilars Sales Market Report 2016

1 BIOLOGICS AND BIOSIMILARS OVERVIEW

1.1 Product Overview and Scope of Biologics and Biosimilars
1.2 Classification of Biologics and Biosimilars
  1.2.1 Classification by Technology
  1.2.2 Classification by Types
  1.2.3 Classification by Use
  1.2.4 Classification by Services
1.3 Application of Biologics and Biosimilars
  1.3.1 Tumor
  1.3.2 Diabetes
  1.3.3 Cardiovascular
  1.3.4 Hemophilia
  1.3.5 Other
1.4 Biologics and Biosimilars Market by Regions
  1.4.1 USA Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 India Status and Prospect (2011-2021)
  1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Biologics and Biosimilars (2011-2021)
  1.5.1 Global Biologics and Biosimilars Sales and Growth Rate (2011-2021)
  1.5.2 Global Biologics and Biosimilars Revenue and Growth Rate (2011-2021)

2 GLOBAL BIOLOGICS AND BIOSIMILARS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Biologics and Biosimilars Market Competition by Manufacturers
  2.1.1 Global Biologics and Biosimilars Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Biologics and Biosimilars Revenue and Share by Manufacturers (2011-2016)
2.2 Global Biologics and Biosimilars (Volume and Value) by Type
  2.2.1 Global Biologics and Biosimilars Sales and Market Share by Type (2011-2016)
  2.2.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2011-2016)
2.3 Global Biologics and Biosimilars (Volume and Value) by Regions
  2.3.1 Global Biologics and Biosimilars Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Biologics and Biosimilars Revenue and Market Share by Regions (2011-2016)
2.4 Global Biologics and Biosimilars (Volume) by Application

3 USA BIOLOGICS AND BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

3.1 USA Biologics and Biosimilars Sales and Value (2011-2016)
  3.1.1 USA Biologics and Biosimilars Sales and Growth Rate (2011-2016)
  3.1.2 USA Biologics and Biosimilars Revenue and Growth Rate (2011-2016)
  3.1.3 USA Biologics and Biosimilars Sales Price Trend (2011-2016)
3.2 USA Biologics and Biosimilars Sales and Market Share by Manufacturers
3.3 USA Biologics and Biosimilars Sales and Market Share by Type
3.4 USA Biologics and Biosimilars Sales and Market Share by Application

4 CHINA BIOLOGICS AND BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

4.1 China Biologics and Biosimilars Sales and Value (2011-2016)
  4.1.1 China Biologics and Biosimilars Sales and Growth Rate (2011-2016)
  4.1.2 China Biologics and Biosimilars Revenue and Growth Rate (2011-2016)
  4.1.3 China Biologics and Biosimilars Sales Price Trend (2011-2016)
4.2 China Biologics and Biosimilars Sales and Market Share by Manufacturers
4.3 China Biologics and Biosimilars Sales and Market Share by Type
4.4 China Biologics and Biosimilars Sales and Market Share by Application

5 EUROPE BIOLOGICS AND BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Biologics and Biosimilars Sales and Value (2011-2016)
  5.1.1 Europe Biologics and Biosimilars Sales and Growth Rate (2011-2016)
  5.1.2 Europe Biologics and Biosimilars Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Biologics and Biosimilars Sales Price Trend (2011-2016)
5.2 Europe Biologics and Biosimilars Sales and Market Share by Manufacturers
5.3 Europe Biologics and Biosimilars Sales and Market Share by Type
5.4 Europe Biologics and Biosimilars Sales and Market Share by Application

6 JAPAN BIOLOGICS AND BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Biologics and Biosimilars Sales and Value (2011-2016)
  6.1.1 Japan Biologics and Biosimilars Sales and Growth Rate (2011-2016)
  6.1.2 Japan Biologics and Biosimilars Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Biologics and Biosimilars Sales Price Trend (2011-2016)
6.2 Japan Biologics and Biosimilars Sales and Market Share by Manufacturers
6.3 Japan Biologics and Biosimilars Sales and Market Share by Type
6.4 Japan Biologics and Biosimilars Sales and Market Share by Application

7 INDIA BIOLOGICS AND BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

7.1 India Biologics and Biosimilars Sales and Value (2011-2016)
  7.1.1 India Biologics and Biosimilars Sales and Growth Rate (2011-2016)
  7.1.2 India Biologics and Biosimilars Revenue and Growth Rate (2011-2016)
  7.1.3 India Biologics and Biosimilars Sales Price Trend (2011-2016)
7.2 India Biologics and Biosimilars Sales and Market Share by Manufacturers
7.3 India Biologics and Biosimilars Sales and Market Share by Type
7.4 India Biologics and Biosimilars Sales and Market Share by Application

8 SOUTHEAST ASIA BIOLOGICS AND BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Biologics and Biosimilars Sales and Value (2011-2016)
  8.1.1 Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2011-2016)
  8.1.2 Southeast Asia Biologics and Biosimilars Revenue and Growth Rate (2011-2016)
  8.1.3 Southeast Asia Biologics and Biosimilars Sales Price Trend (2011-2016)
8.2 Southeast Asia Biologics and Biosimilars Sales and Market Share by Manufacturers
8.3 Southeast Asia Biologics and Biosimilars Sales and Market Share by Type
8.4 Southeast Asia Biologics and Biosimilars Sales and Market Share by Application

9 GLOBAL BIOLOGICS AND BIOSIMILARS MANUFACTURERS ANALYSIS

9.1 Pfizer
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Biologics and Biosimilars Product Type, Application and Specification
    9.1.2.1 Type I
    9.1.2.2 Type II
  9.1.3 Pfizer Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  9.1.4 Main Business/Business Overview
9.2 Roche
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 120 Product Type, Application and Specification
    9.2.2.1 Type I
    9.2.2.2 Type II
  9.2.3 Roche Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  9.2.4 Main Business/Business Overview
9.3 Amgen
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 142 Product Type, Application and Specification
    9.3.2.1 Type I
    9.3.2.2 Type II
  9.3.3 Amgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  9.3.4 Main Business/Business Overview
9.4 AbbVie
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Sep Product Type, Application and Specification
    9.4.2.1 Type I
    9.4.2.2 Type II
  9.4.3 AbbVie Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  9.4.4 Main Business/Business Overview
9.5 Sanofi
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Product Type, Application and Specification
    9.5.2.1 Type I
    9.5.2.2 Type II
  9.5.3 Sanofi Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  9.5.4 Main Business/Business Overview
9.6 Johnson & Johnson
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Million USD Product Type, Application and Specification
    9.6.2.1 Type I
    9.6.2.2 Type II
  9.6.3 Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  9.6.4 Main Business/Business Overview
9.7 Novo Nordisk
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Pharmaceuticals Product Type, Application and Specification
    9.7.2.1 Type I
    9.7.2.2 Type II
  9.7.3 Novo Nordisk Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  9.7.4 Main Business/Business Overview
9.8 Novartis
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Product Type, Application and Specification
    9.8.2.1 Type I
    9.8.2.2 Type II
  9.8.3 Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  9.8.4 Main Business/Business Overview
9.9 Merck
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Product Type, Application and Specification
    9.9.2.1 Type I
    9.9.2.2 Type II
  9.9.3 Merck Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  9.9.4 Main Business/Business Overview
9.10 Lilly
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Product Type, Application and Specification
    9.10.2.1 Type I
    9.10.2.2 Type II
  9.10.3 Lilly Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  9.10.4 Main Business/Business Overview
9.11 3sbio
9.12 Changchun high tech
9.13 CP Guojian Pharmacy
9.14 Biotech Pharma
9.15 Gelgen Biopharma
9.16 Sandoz
9.17 Teva
9.18 Hospira
9.19 Mylan
9.20 3sbio
9.21 Changchun high tech
9.22 CP Guojian Pharmacy
9.23 Biotech Pharma
9.24 Gelgen Biopharma

10 BIOLOGICS AND BIOSIMILARS MAUFACTURING COST ANALYSIS

10.1 Biologics and Biosimilars Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Biologics and Biosimilars

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Biologics and Biosimilars Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL BIOLOGICS AND BIOSIMILARS MARKET FORECAST (2016-2021)

14.1 Global Biologics and Biosimilars Sales, Revenue Forecast (2016-2021)
14.2 Global Biologics and Biosimilars Sales Forecast by Regions (2016-2021)
14.3 Global Biologics and Biosimilars Sales Forecast by Type (2016-2021)
14.4 Global Biologics and Biosimilars Sales Forecast by Application (2016-2021)

15 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of Biologics and Biosimilars
Table Classification of Biologics and Biosimilars
Figure Global Sales Market Share of Biologics and Biosimilars by Type in 2015
Figure Classification by Technology Picture
Figure Classification by Types Picture
Figure Classification by Use Picture
Figure Classification by Services Picture
Table Applications of Biologics and Biosimilars
Figure Global Sales Market Share of Biologics and Biosimilars by Application in 2015
Figure Tumor Examples
Figure Diabetes Examples
Figure Cardiovascular Examples
Figure Hemophilia Examples
Figure Other Examples
Figure USA Biologics and Biosimilars Revenue and Growth Rate (2011-2021)
Figure China Biologics and Biosimilars Revenue and Growth Rate (2011-2021)
Figure Europe Biologics and Biosimilars Revenue and Growth Rate (2011-2021)
Figure Japan Biologics and Biosimilars Revenue and Growth Rate (2011-2021)
Figure India Biologics and Biosimilars Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Biologics and Biosimilars Revenue and Growth Rate (2011-2021)
Figure Global Biologics and Biosimilars Sales and Growth Rate (2011-2021)
Figure Global Biologics and Biosimilars Revenue and Growth Rate (2011-2021)
Table Global Biologics and Biosimilars Sales of Key Manufacturers (2011-2016)
Table Global Biologics and Biosimilars Sales Share by Manufacturers (2011-2016)
Figure 2015 Biologics and Biosimilars Sales Share by Manufacturers
Figure 2016 Biologics and Biosimilars Sales Share by Manufacturers
Table Global Biologics and Biosimilars Revenue by Manufacturers (2011-2016)
Table Global Biologics and Biosimilars Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Biologics and Biosimilars Revenue Share by Manufacturers
Table 2016 Global Biologics and Biosimilars Revenue Share by Manufacturers
Table Global Biologics and Biosimilars Sales and Market Share by Type (2011-2016)
Table Global Biologics and Biosimilars Sales Share by Type (2011-2016)
Figure Sales Market Share of Biologics and Biosimilars by Type (2011-2016)
Figure Global Biologics and Biosimilars Sales Growth Rate by Type (2011-2016)
Table Global Biologics and Biosimilars Revenue and Market Share by Type (2011-2016)
Table Global Biologics and Biosimilars Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Biologics and Biosimilars by Type (2011-2016)
Figure Global Biologics and Biosimilars Revenue Growth Rate by Type (2011-2016)
Table Global Biologics and Biosimilars Sales and Market Share by Regions (2011-2016)
Table Global Biologics and Biosimilars Sales Share by Regions (2011-2016)
Figure Sales Market Share of Biologics and Biosimilars by Regions (2011-2016)
Figure Global Biologics and Biosimilars Sales Growth Rate by Regions (2011-2016)
Table Global Biologics and Biosimilars Revenue and Market Share by Regions (2011-2016)
Table Global Biologics and Biosimilars Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Biologics and Biosimilars by Regions (2011-2016)
Figure Global Biologics and Biosimilars Revenue Growth Rate by Regions (2011-2016)
Table Global Biologics and Biosimilars Sales and Market Share by Application (2011-2016)
Table Global Biologics and Biosimilars Sales Share by Application (2011-2016)
Figure Sales Market Share of Biologics and Biosimilars by Application (2011-2016)
Figure Global Biologics and Biosimilars Sales Growth Rate by Application (2011-2016)
Figure USA Biologics and Biosimilars Sales and Growth Rate (2011-2016)
Figure USA Biologics and Biosimilars Revenue and Growth Rate (2011-2016)
Figure USA Biologics and Biosimilars Sales Price Trend (2011-2016)
Table USA Biologics and Biosimilars Sales by Manufacturers (2011-2016)
Table USA Biologics and Biosimilars Market Share by Manufacturers (2011-2016)
Table USA Biologics and Biosimilars Sales by Type (2011-2016)
Table USA Biologics and Biosimilars Market Share by Type (2011-2016)
Table USA Biologics and Biosimilars Sales by Application (2011-2016)
Table USA Biologics and Biosimilars Market Share by Application (2011-2016)
Figure China Biologics and Biosimilars Sales and Growth Rate (2011-2016)
Figure China Biologics and Biosimilars Revenue and Growth Rate (2011-2016)
Figure China Biologics and Biosimilars Sales Price Trend (2011-2016)
Table China Biologics and Biosimilars Sales by Manufacturers (2011-2016)
Table China Biologics and Biosimilars Market Share by Manufacturers (2011-2016)
Table China Biologics and Biosimilars Sales by Type (2011-2016)
Table China Biologics and Biosimilars Market Share by Type (2011-2016)
Table China Biologics and Biosimilars Sales by Application (2011-2016)
Table China Biologics and Biosimilars Market Share by Application (2011-2016)
Figure Europe Biologics and Biosimilars Sales and Growth Rate (2011-2016)
Figure Europe Biologics and Biosimilars Revenue and Growth Rate (2011-2016)
Figure Europe Biologics and Biosimilars Sales Price Trend (2011-2016)
Table Europe Biologics and Biosimilars Sales by Manufacturers (2011-2016)
Table Europe Biologics and Biosimilars Market Share by Manufacturers (2011-2016)
Table Europe Biologics and Biosimilars Sales by Type (2011-2016)
Table Europe Biologics and Biosimilars Market Share by Type (2011-2016)
Table Europe Biologics and Biosimilars Sales by Application (2011-2016)
Table Europe Biologics and Biosimilars Market Share by Application (2011-2016)
Figure Japan Biologics and Biosimilars Sales and Growth Rate (2011-2016)
Figure Japan Biologics and Biosimilars Revenue and Growth Rate (2011-2016)
Figure Japan Biologics and Biosimilars Sales Price Trend (2011-2016)
Table Japan Biologics and Biosimilars Sales by Manufacturers (2011-2016)
Table Japan Biologics and Biosimilars Market Share by Manufacturers (2011-2016)
Table Japan Biologics and Biosimilars Sales by Type (2011-2016)
Table Japan Biologics and Biosimilars Market Share by Type (2011-2016)
Table Japan Biologics and Biosimilars Sales by Application (2011-2016)
Table Japan Biologics and Biosimilars Market Share by Application (2011-2016)
Figure India Biologics and Biosimilars Sales and Growth Rate (2011-2016)
Figure India Biologics and Biosimilars Revenue and Growth Rate (2011-2016)
Figure India Biologics and Biosimilars Sales Price Trend (2011-2016)
Table India Biologics and Biosimilars Sales by Manufacturers (2011-2016)
Table India Biologics and Biosimilars Market Share by Manufacturers (2011-2016)
Table India Biologics and Biosimilars Sales by Type (2011-2016)
Table India Biologics and Biosimilars Market Share by Type (2011-2016)
Table India Biologics and Biosimilars Sales by Application (2011-2016)
Table India Biologics and Biosimilars Market Share by Application (2011-2016)
Figure Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2011-2016)
Figure Southeast Asia Biologics and Biosimilars Revenue and Growth Rate (2011-2016)
Figure Southeast Asia Biologics and Biosimilars Sales Price Trend (2011-2016)
Table Southeast Asia Biologics and Biosimilars Sales by Manufacturers (2011-2016)
Table Southeast Asia Biologics and Biosimilars Market Share by Manufacturers (2011-2016)
Table Southeast Asia Biologics and Biosimilars Sales by Type (2011-2016)
Table Southeast Asia Biologics and Biosimilars Market Share by Type (2011-2016)
Table Southeast Asia Biologics and Biosimilars Sales by Application (2011-2016)
Table Southeast Asia Biologics and Biosimilars Market Share by Application (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Biologics and Biosimilars Global Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Biologics and Biosimilars Global Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Biologics and Biosimilars Global Market Share (2011-2016)
Table AbbVie Basic Information List
Table AbbVie Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AbbVie Biologics and Biosimilars Global Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi Biologics and Biosimilars Global Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson & Johnson Biologics and Biosimilars Global Market Share (2011-2016)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novo Nordisk Biologics and Biosimilars Global Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Biologics and Biosimilars Global Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Biologics and Biosimilars Global Market Share (2011-2016)
Table Lilly Basic Information List
Table Lilly Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Lilly Biologics and Biosimilars Global Market Share (2011-2016)
Table 3sbio Basic Information List
Table 3sbio Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure 3sbio Biologics and Biosimilars Global Market Share (2011-2016)
Table Changchun high tech Basic Information List
Table Changchun high tech Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Changchun high tech Biologics and Biosimilars Global Market Share (2011-2016)
Table CP Guojian Pharmacy Basic Information List
Table CP Guojian Pharmacy Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure CP Guojian Pharmacy Biologics and Biosimilars Global Market Share (2011-2016)
Table Biotech Pharma Basic Information List
Table Biotech Pharma Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Biotech Pharma Biologics and Biosimilars Global Market Share (2011-2016)
Table Gelgen Biopharma Basic Information List
Table Gelgen Biopharma Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Gelgen Biopharma Biologics and Biosimilars Global Market Share (2011-2016)
Table Sandoz Basic Information List
Table Sandoz Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sandoz Biologics and Biosimilars Global Market Share (2011-2016)
Table Teva Basic Information List
Table Teva Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Teva Biologics and Biosimilars Global Market Share (2011-2016)
Table Hospira Basic Information List
Table Hospira Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Hospira Biologics and Biosimilars Global Market Share (2011-2016)
Table Mylan Basic Information List
Table Mylan Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Mylan Biologics and Biosimilars Global Market Share (2011-2016)
Table 3sbio Basic Information List
Table 3sbio Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure 3sbio Biologics and Biosimilars Global Market Share (2011-2016)
Table Changchun high tech Basic Information List
Table Changchun high tech Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Changchun high tech Biologics and Biosimilars Global Market Share (2011-2016)
Table CP Guojian Pharmacy Basic Information List
Table CP Guojian Pharmacy Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure CP Guojian Pharmacy Biologics and Biosimilars Global Market Share (2011-2016)
Table Biotech Pharma Basic Information List
Table Biotech Pharma Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Biotech Pharma Biologics and Biosimilars Global Market Share (2011-2016)
Table Gelgen Biopharma Basic Information List
Table Gelgen Biopharma Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Gelgen Biopharma Biologics and Biosimilars Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biologics and Biosimilars
Figure Manufacturing Process Analysis of Biologics and Biosimilars
Figure Biologics and Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015
Table Major Buyers of Biologics and Biosimilars
Table Distributors/Traders List
Figure Global Biologics and Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure Global Biologics and Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Table Global Biologics and Biosimilars Sales Forecast by Regions (2016-2021)
Table Global Biologics and Biosimilars Sales Forecast by Type (2016-2021)
Table Global Biologics and Biosimilars Sales Forecast by Application (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories